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Streptococcus pneumoniaeintracranial abscess and post-infectious vasculitis
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Abstract
Intracranial abscesses are rare complica-
tions of Streptococcus pneumoniae infections,
and to our knowledge, there have been no case
reports of post-infectious vasculitis developing
in such patients. Here we describe the case of
a 48-year-old post-splenectomy male who
developed post-infectious vasculitis following
S. pneumoniae otitis media complicated by
mastoiditis, osteomyelitis, meningitis, and
intracranial abscess. Clinicians ought to be
aware of the possible adverse outcomes of
invasive S. pneumoniae and the limitations of
current treatment options. 
Introduction
Streptococcus pneumoniae intracranial
abscess is a rare complication of pneumococ-
cal infections, with the majority of cases being
reported in the pre-antibiotic era. Today, the
survival rate and long-term outcome of these
patients remains quite poor, with up to 35%
mortality and 40% experiencing prolonged
neurological deficits.1,2 Most infections occur
as a result of contiguous infection, with
paranasal sinus and the middle ear being the
most common sources.3 Post-infectious vas-
culitis is an uncommon complication of S.
pneumoniae, with arterial cerebrovascular
complications occurring in up to 21.8% of S.
pneumoniae meningitis.4 To our knowledge, no
case report has identified post-infectious vas-
culitis occurring after S. pneumoniae abscess
in an adult. Here, we report a case of a 48yo
male who developed post-infectious vasculitis
following S. pneumoniae otitis media, mas-
toiditis, osteomyelitis, meningitis and abscess.
Case Report
Our patient is a 48 year-old male patient
with childhood splenectomy and no pneumo-
coccal vaccine who initially presented to an
outside emergency department (ED) with ear
pain and headache. He was given amoxicillin
and hydrocodone bitartrate plus acetamino-
phen and was discharged home. That night he
developed altered mental status, becoming
uncommunicative and unable to follow com-
mands. He re-presented to the same ED and
found to be hypertensive and febrile, with a
Glascow coma scale (GCS) score of 13 without
focal motor or sensory deficits. A complete
blood count revealed leukocytosis with a white
blood cell (WBC) count of 51×103/mcL (refer-
ence value 4.0-10.0×103/mcL). An MRI demon-
strated a left 4×4×3 cm heterogenous multi-
loculated mass extending intracranially from
the mastoid air cells, consistent with mastoid
abscess and osteomyelitis (Figure 1A). An
epidural abscess, sigmoid sinus and jugular
thrombosis were also seen (Figure 1B).
Lumbar puncture showed 2600 white blood
cells per mcl (reference value 0-5/mcL), 250
red blood cells per mcL (reference value 0-
5/mcL), total protein content of 924 mg/dL (ref-
erence value 15-45 mg/dL), glucose <1 mg/dL.
Gram staining revealed neutrophils and gram-
positive diplococci. He was transferred to our
hospital, where he was taken to the operating
room for mastoidectomy, craniotomy, and CSF
shunt placement with evacuation of
intradiploic skull mass and epidural abscess.
Pathology of skull mass demonstrated a benign
epithelial inclusion cyst with lymphocytic infil-
trate. Initial antibiotic regimen included IV
vancomycin, ceftriaxone, and steroid regimen
of IV dexamethasone. Mastoid fluid culture
revealed S. pneumoniae resistant to penicillin
and ceftriaxone (unusual in our institution)
and ceftriaxone was changed to rifampin. His
status improved over the next 8 days, and he
was discharged on hospital day (HD) 8 with an
ongoing headache well controlled with oxy-
codone, a Montreal Cognitive Assessment
(MOCA) of 19/30, and a decreasing leukocyto-
sis (white blood cell count 20.2×103/mcL). At
discharge, he remained on IV vancomycin and
PO rifampin for a planned six-week course,
and a two week PO dexamethasone taper start-
ing from 10mg PO bid. 
Two days after discharge, he re-presented to
the outside ED with worsening temporal
headache. His neurological exam was normal,
but he was febrile to 38.2 C. A complete blood
cell count revealed 22.6×103/mcL white blood
cells, platelets 900×103/mcL (reference 145-
370×103/mcL), and a new anemia, with hemo-
globin of 11.4 gm/dL (reference range 13.7-
17.5 gm/dL). A CT head revealed persistent
opacification of residual left mastoid. He was
begun on levofloxacin in addition to his van-
comycin and rifampin, and transferred to our
hospital. An MRI obtained at our institution
demonstrated increased meningeal enhance-
ment and new left cerebellar enhancement
that was consistent with either post-surgical
change or cerebellitis. His LP was consistent
with persistent signs of infection versus
inflammation (WBC 846 cells per mcL, protein
168 mg/dL, and glucose 4 mg/dL). His IV dex-
amethasone was empirically increased to 10
mg IV. On HD2, he developed sudden-onset of
slurred speech and right facial droop; a CT did
not demonstrate any new infarcts. Over the
next 3 days, he remained febrile, dysarthric,
confused, and agitated. His dexamethasone
was decreased to 6 mg and then 4 mg bid to
allow for better penetration of antibiotics.
Given his ongoing signs of infection, ceftaro-
line was added to his regimen and levofloxacin
replaced by moxifloxacin. Multiple blood and
CSF cultures demonstrated no growth. On
HD10, a stroke alert was activated due to unre-
sponsiveness to voice and sternal rub.  A CT
head demonstrated a subacute lacunar infarct
of the left basal ganglia and corona radiate,
and levetiracetam was begun for seizure pro-
phylaxis. An MRI the following day showed sev-
eral punctate areas of restricted diffusion,
most likely small areas of infarct consistent
with post-infectious vasculitis (Figure 2). His
dexamethasone was increased to 8 mg IV q8h,
and his obtundation improved the next day. No
intravenous immunoglobulin (IVIG) was
given.  Over the course of the next 47 days, he
had fluctuating mental status that gradually
improved. Consulting services during admis-
sion included neurosurgery, ENT, infectious
disease, and neurology. His course was compli-
cated by thrush, red man syndrome, hypona-
tremia secondary to SIADH, and urinary reten-
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tion. He was maintained on a prolonged
steroid taper and completed an additional 4
week course of vancomycin, rifampin, ceftaro-
line, and moxifloxacin. On HD46, he under-
went an interventional radiology-guided mas-
toid fluid drainage, which showed only few
WBCs without organisms or growth. On HD57,
he was discharged home following an MRI that
showed evolution of his old infarcts and no
new disease. Post-discharge, his cognition,
memory and motor function continued to grad-
ually improved. Unfortunately, he died a few
months later as a passenger in a single motor
vehicle accident before full neurological recov-
ery was achieved.
Discussion
This complex case highlights the risk of vas-
cular involvement in invasive pneumococcal
infections. Patients with S. pneumoniae infec-
tions are at particular risk of such complica-
tions given the pro-inflammatory cascade trig-
gered by the bacteria, regardless of initial
antibiotic therapy.5 Markers of both neuronal,
glial, and myelin destruction have been identi-
fied in S. pneumoniae meningitis patients,
likely due to streptococcal cell wall induced
cytokine toxicity.6
Our patient was at higher risk of invasive S.
pneumoniae infection given his history of
splenectomy without pneumococcal vaccina-
tion and of benign epithelial inclusion cyst.
Underlying chronic predispositions for infec-
tion are found in over 40% of patients, with
chronic alcoholism, asplenia, diabetes melli-
tus, and malignancy being among the most
common.4,7 The majority of patients present
with an associated infection, mainly ear or
sinus infections or pneumonias.4 Nonetheless,
pneumococcal abscesses remain very rare,
with the majority of reported cases occurring
in the pre-antibiotic era.1
Given the rarity of post-infectious vasculitis,
there is no consensus on treatment for S.
pneumoniae cerebral vasculitis.
Corticosteroids are effective in preventing
complications of meningitis, e.g. sensorineural
hearing loss, if given very early in the course of
treatment (prior to or at the time of antibi-
otics). Although treatment is typically limited
to less than four days, some reports have sug-
gested a rebound inflammatory effect whereby
steroid withdrawal can result in increased vas-
cular inflammation.5 Our patient’s course adds
to this growing body of literature, given his
progression while on a prolonged taper of
steroids. The role of IVIG is not well-estab-
lished in this population, although it is used in
isolated cases of non-infectious cerebral vas-
culitis. However, IVIG and glucocorticoids have
been reported to be efficacious in patients
with post-infectious vasculitis.6 Although our
patient did not receive IVIG, this is a possible
treatment option that ought to be considered.  
Conclusions
This report highlights the post-infectious
vascular complications of invasive pneumococ-
cal disease in an at-risk patients. Clinicians
should be aware of the severity of illness and
the possible adverse outcomes of S. pneumoni-
ae. More research needs to be done in order to
establish the various roles of antibiotics, glu-
cocorticoids, and IVIG treatments so that we
can effectively manage these patients in the
future. 
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Figure 1. Patient MRA obtained on HD1 of first admission. A) T1-weighted precontrast
imaging demonstrating a 3×4 cm area of high signal intensity extending posteriorly from
the left mastoid, consistent with mastoid abscess versus osteomyelitis. B) MRV demon-
strating sigmoid sinus and jugular thrombosis.
Figure 2. T2-weighted MRI obtained on
HD11 of second admission, demonstrat-
ing punctate areas of restricted diffusion,
most likely small areas of infarct consis-
tent with post-infectious vasculitis.
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